Iván Álvarez

Integrated Strategy Lead, Roche Schweiz

[Edmund Tsui, MD @EdmundTsuiMD]

Our new @AJOphthalmology study led by @GangaputraSapna, finds #uveitis workforce shortage driven by limited fellowship uptake, projections suggesting 1/3 decline by 2055.

👉Expanding trainee pipeline is essential to preserve access to subspecialty care.

https://t.co/wSD69Icdc6

[Figs From Plums @FigsFromPlums]

Dotary - A braille e-book device for the visually impaired - Designed by Hyeokin Kwon, Hanju Kim, and Chaelynn Park

[IOB.ch @IOB_ch]

🧬 BREAKTHROUGH: IOB researchers have identified a new genetic cause of inherited blindness in previously unexplored regions of the genome.
Published today in @NatureGenet
🧵Thread ⬇️

[Interpharma @interpharma_ch]

"Es ist eine einfache Rechnung: Hier kommen 10% des BIP von der Pharmaindustrie und den dazugehörigen Lieferketten. Allein die Steuereinnahmen der Pharmabranche betragen pro Jahr 4 Milliarden Franken. Das heisst, allein die Steuern sind höher als das, was man im Land für innovative Medikamente ausgibt." https://t.co/g8oiAVH6kT

[Ophthalmology @AAOjournal]

Classification of Diabetic Retinopathy Severity with Aqueous VEGF Levels: A Prospective, Observational Study
https://t.co/0rYwG3CTch
#ophthalmology

[René Buholzer @RBuholzer]

Warum warten Patienten in der Schweiz länger auf lebenswichtige Therapien?

https://t.co/QF9iLmtzdF

[EURETINA @EURETINA]

Today is World Retina Day

With over 100 million people living with retinal diseases, World Retina Day is a reminder of the importance of early detection, research and awareness to protect vision.

To read more, visit: https://t.co/FrW95lEsqz

#WorldRetinaDay #Euretina

[EURETINA @EURETINA]

#EIS starts today in Paris!

A day dedicated to cutting-edge innovation in retinal treatment, biotech pitches and live discussions.

📲 Follow our posts on X, for behind the-scenes moments and session highlights!

#EURETINA25 #EIS2025 #RetinalInnovation

[Ophthalmology @AAOjournal]

New big data study using the @aao_ophth IRIS Registry reports on the prevalence, treatment patterns, & outcomes of pediatric non-infectious #uveitis in the United States.
https://t.co/ektLRHb0Y9
#ophthalmology #retina

[EURETINA @EURETINA]

📢 Calling all Trainee Vitreoretinal Surgeons under 40!

Does your case have what it takes?

Then it is time to submit to #EuroVeRsion 2025! 🎥🌍

🗓️ Deadline: 30 May 2025, 23:59 CEST
🔗 https://t.co/kBzta6vgAg

#Euretina2025 #RetinaSurgery #RetinaTrainees #VRUnder40

[EyeSmart @AcademyEyeSmart]

Don’t consult Dr. ChatGPT. Researchers found the chatbot only answers common eye health qs accurately 15% of the time. Subscribe to EyeSmart instead for physician-approved articles delivered monthly to your inbox: https://t.co/5QQNDvp4F9

#newsletter #signup #eyehealth

[Young Retina Specialists @YoungRetina]

🚨Last call, young retina specialists! 🚨

🗓️Tomorrow marks the deadline for applications to the EURETINA Mentorship Programme.

Don't let this chance slip away!

Apply now: https://t.co/8CsVcmD60L

#EURETINA #Retina #Mentorship #CareerDevelopment

[Sociedad Española de Retina y Vítreo @RetinaSERV]

📡 ¡Regresa el OCT Summer Camp en su tercera edición!

Del 19 al 21 de junio de 2025 en Valencia, un curso monográfico único sobre adquisición e interpretación de imágenes de OCT.

📌 Más información en la bio.

[Iván Álvarez @ivanalvarez100]

@Amaximedes @JavierZarranz Enhorabuena a todos por el gran resultado de este estudio. Una evidencia mas para asegurarnos de que prevenimos dichas fluctuaciones

[Maxi Abraldes @Amaximedes]

Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothel… https://t.co/HeJDTRU0K9 Otro granito de arena que aportamos a la ciencia. En esta ocasión bajo el liderazgo de @JavierZarranz

[EURETINA @EURETINA]

📺 Relive the Highlights of #EURETINA24

Missed a session or want to revisit your favorite talks? The playback of the EURETINA Congress in Barcelona is available until 31 December 2024!

🔗https://t.co/KxxeDaPGzw

#RetinaCare #EURETINA24 #OnDemand #Ophthalmology

[European Blind Union @euroblind]

Are you a #VisuallyImpaired person living in Switzerland?

SBV-FSA have launched their third 2024 issue of their magazine "Clin d'œil". 

French: https://t.co/b8cV0EYg2G 
German: https://t.co/W4BT9w1RYl 

👇 For more information about their activities.
https://t.co/lCYZuekYF4

[The Ophthalmologist @OphthoMag]

Shriji Patel (@vitreouscutter) examines the present and future state of the #ophthalmology workforce in the US 🌎
https://t.co/yZPh2wOxUj

[JAMA Ophthalmology @JAMAOphth]

Age-related macular degeneration causes severe vision impairment in older adults. This JAMA Patient Page describes AMD development and progression; symptoms and risk factors; and diagnosis, monitoring, and treatment. https://t.co/ty7CJFe4cn

[OCU @consumidores]

#Salud @EMA_News suspende la comercialización de un amplio número de medicamentos genéricos al comprobar que los datos de bioequivalencia son deficientes.
➡Consulta la lista de los medicamentos "bajo sospecha" 👇
https://t.co/RTvn1NJs3v